National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Estimated Value: $1,500,000
Open 186 days left Healthcaregrant
Nov 12, 2024
Jan 7, 2027 12:00 AM
Healthcare
grant
AI Summary
This is a funding opportunity from the National Cancer Institute for investigator-initiated early phase clinical trials focused on cancer treatment and diagnosis. It requires an R01 clinical trial application and falls under CFDA numbers 93.393, 93.399, 93.394, and 93.395.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Early Phase Clinical Trial for Cancer Treatment 1 each $500,000.00 $500,000.00 Medical
Early Phase Clinical Trial for Cancer Diagnosis 1 each $500,000.00 $500,000.00 Medical
R01 Clinical Trial Implementation and Management 1 each $500,000.00 $500,000.00 Professional Services
Estimated Bid Value$1,500,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids